Hyperandrogenemia in obese peripubertal girls: Correlates and potential Etiological determinants

Obesity

Volumn 18, Issue 11, 2010, Pages 2118-2124

  Knudsen, Karen L ^a   Blank, Susan K ^a   Solorzano, Christine Burt ^a,b   Patrie, James T ^b   Chang, R Jeffrey ^c   Caprio, Sonia ^d   Marshall, John C ^a   McCartney, Christopher R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADOLESCENT; ARTICLE; BLOOD; BODY MASS; CHILD; DIET RESTRICTION; FEMALE; HUMAN; HYPERINSULINISM; OBESITY; OVARY POLYCYSTIC DISEASE; PUBERTY; REGRESSION ANALYSIS;

ADOLESCENT; BODY MASS INDEX; CHILD; FASTING; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; LUTEINIZING HORMONE; OBESITY; POLYCYSTIC OVARY SYNDROME; PUBERTY; REGRESSION ANALYSIS; TESTOSTERONE;

EID: 78049251285     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.58     Document Type: Article

References (30)

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352: 1223-1236.
2. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F (eds). Polycystic Ovary Syndrome. Blackwell Scientific: Boston, 1992, pp. 377-384.
3. Azziz R, Carmina E, Dewailly D et al.; Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-4245.
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
5. Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update 2006;12:351-361.
6. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995;16:322-353.
7. Franks S. Adult polycystic ovary syndrome begins in childhood. Best Pract Res Clin Endocrinol Metab 2002;16:263-272.
8. Witchel S F. Puberty and polycystic ovary syndrome. Mol Cell Endocrinol 2006;254-255:146-153.
9. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002;26: 883-896.
10. Reinehr T, de Sousa G, Roth CL, Andler W. Androgens before and after weight loss in obese children. J Clin Endocrinol Metab 2005;90:5588-5595.
11. McCartney CR, Prendergast KA, Chhabra S et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab 2006;91:1714-1722.
12. McCartney CR, Blank SK, Prendergast KA et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre-and early pubertal obese girls. J Clin Endocrinol Metab 2007;92:430-436.
13. Bordini B, Littlejohn E, Rosenfield RL. Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. J Clin Endocrinol Metab 2009;94:1168-1175.
14. Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:787-796.
15. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000:27.
16. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120 Suppl 4:S164-S192.
17. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
18. McCartney CR, Prendergast KA, Blank SK et al. Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. J Clin Endocrinol Metab 2009;94:56-66.
19. Venturoli S, Porcu E, Fabbri R et al. Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertil Steril 1987;48:78-85.
20. Waldstreicher J, Santoro N F, Hall JE, Filicori M, Crowley WF Jr. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988;66:165-172.
21. Apter D, Bützow T, Laughlin GA, Yen SS. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab 1994;79:119-125.
22. Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 1998;83:582-590.
23. Eagleson CA, Gingrich MB, Pastor CL et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 2000;85:4047-4052.
24. Chhabra S, McCartney CR, Yoo RY et al. Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: evidence for varied effects in hyperandrogenemic adolescent girls. J Clin Endocrinol Metab 2005;90:2810-2815.
25. Blank SK, McCartney CR, Chhabra S et al. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls-implications for regulation of pubertal maturation. J Clin Endocrinol Metab 2009;94:2360-2366.
26. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999;20: 535-582.
27. Corbould A. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? Diabetes Metab Res Rev 2008;24:520-532.
28. Boyar R, Finkelstein J, Roffwarg H et al. Synchronization of augmented luteinizing hormone secretion with sleep during puberty. N Engl J Med 1972;287:582-586.
29. Apter D, Bützow TL, Laughlin GA, Yen SS. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. J Clin Endocrinol Metab 1993;76:940-949.
30. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006;60:759-763.